91 related articles for article (PubMed ID: 11869268)
1. Link between intracellular pathogens and cardiovascular diseases.
Gurfinkel E
Clin Microbiol Infect; 1998 Jan; 4 Suppl 4():S33-S36. PubMed ID: 11869268
[TBL] [Abstract][Full Text] [Related]
2. Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation.
Adiloglu AK; Ocal A; Can R; Duver H; Yavuz T; Aridogan BC
Saudi Med J; 2005 Jul; 26(7):1068-74. PubMed ID: 16047055
[TBL] [Abstract][Full Text] [Related]
3. [Infection and coronary atherosclerosis: the role Chlamydia pneumonia].
Paz M; de Otero J; Codinach P; Ferrer-Ruscalleda F; Gayà M; Ibernón M
Rev Esp Cardiol; 1998 Nov; 51(11):857-63. PubMed ID: 9859707
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of Chlamydia pneumoniae.
Blasi F; Tarsia P; Arosio C; Fagetti L; Allegra L
Clin Microbiol Infect; 1998 Jan; 4 Suppl 4():S1-S6. PubMed ID: 11869264
[TBL] [Abstract][Full Text] [Related]
5. Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae.
Song YG; Kwon HM; Kim JM; Hong BK; Kim DS; Huh AJ; Chang KH; Kim HY; Kang TS; Lee BK; Choi DH; Jang YS; Kim HS
Yonsei Med J; 2000 Jun; 41(3):319-27. PubMed ID: 10957885
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia pneumoniae and atherosclerosis: the role of mast cells.
Di Pietro M; Schiavoni G; Del Piano M; Shaik Y; Boscolo P; Caraffa A; Grano M; Teté S; Conti F; Sessa R
J Biol Regul Homeost Agents; 2009; 23(2):65-9. PubMed ID: 19589286
[TBL] [Abstract][Full Text] [Related]
7. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target.
Ismail A; Khosravi H; Olson H
Heart Dis; 1999; 1(4):233-40. PubMed ID: 11720630
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia pneumoniae and vascular disease: an update.
Mussa FF; Chai H; Wang X; Yao Q; Lumsden AB; Chen C
J Vasc Surg; 2006 Jun; 43(6):1301-7. PubMed ID: 16765261
[TBL] [Abstract][Full Text] [Related]
9. Does Chlamydia pneumoniae cause coronary heart disease?
Quinn TC
Curr Opin Infect Dis; 1998 Jun; 11(3):301-7. PubMed ID: 17033395
[TBL] [Abstract][Full Text] [Related]
10. Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by the polymerase chain reaction.
Latsios G; Saetta A; Michalopoulos NV; Agapitos E; Patsouris E
Acta Cardiol; 2004 Dec; 59(6):652-7. PubMed ID: 15636450
[TBL] [Abstract][Full Text] [Related]
11. [Mycoplasma pneumoniae and Chlamydia pneumoniae are associated to inflammation and rupture of the atherosclerotic coronary plaques].
Ramires JA; Higuchi Mde L
Rev Esp Cardiol; 2002; 55 Suppl 1():2-9. PubMed ID: 15626350
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of intimal pathogen burden in acute coronary syndromes].
Andrié R; Braun P; Heinrich KW; Lüderitz B; Bauriedel G
Z Kardiol; 2003 Aug; 92(8):641-9. PubMed ID: 12955411
[TBL] [Abstract][Full Text] [Related]
13. Association of Chlamydia pneumoniae Infection With Atherosclerotic Plaque Formation.
Assar O; Nejatizadeh A; Dehghan F; Kargar M; Zolghadri N
Glob J Health Sci; 2015 Sep; 8(4):260-7. PubMed ID: 26573036
[TBL] [Abstract][Full Text] [Related]
14. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
[TBL] [Abstract][Full Text] [Related]
15. Detection of infectious agents by polymerase chain reaction in human aortic wall.
Reszka E; Jegier B; Wasowicz W; Lelonek M; Banach M; Jaszewski R
Cardiovasc Pathol; 2008; 17(5):297-302. PubMed ID: 18402822
[TBL] [Abstract][Full Text] [Related]
16. Preclinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholesterolemic mice.
Campbell LA; Moazed TC; Kuo CC; Grayston JT
Clin Microbiol Infect; 1998 Jan; 4 Suppl 4():S23-S32. PubMed ID: 11869267
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
18. [Persistence of Chlamydia pneumoniae in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris].
Bauriedel G; Andrié R; Likungu JA; Welz A; Braun P; Welsch U; Lüderitz B
Dtsch Med Wochenschr; 1999 Nov; 124(47):1408-13. PubMed ID: 10605420
[TBL] [Abstract][Full Text] [Related]
19. Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction.
Kaplan M; Yavuz SS; Cinar B; Koksal V; Kut MS; Yapici F; Gercekoglu H; Demirtas MM
Int J Infect Dis; 2006 Mar; 10(2):116-23. PubMed ID: 16183317
[TBL] [Abstract][Full Text] [Related]
20. [Chlamydia pneumoniae and atherosclerosis].
Fortini A; Corti G; Cappelletti C
Ann Ital Med Int; 1999; 14(4):253-63. PubMed ID: 10638018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
